MLICM
ALBO

Metropolitan Life Insurance Company (MetLife)’s Albireo Pharma Inc ALBO Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,087
Closed -$23.5K – 2515
2022
Q4 		$23.5K Hold
1,087
– – ﹤0.01% 1926
2022
Q3 		$21K Hold
1,087
– – ﹤0.01% 2006
2022
Q2 		$21.6K Hold
1,087
– – ﹤0.01% 2019
2022
Q1 		$32.4K Sell
1,087
-3,466
-76% -$101K ﹤0.01% 1838
2021
Q4 		$106K Hold
4,553
– – ﹤0.01% 2443
2021
Q3 		$142K Hold
4,553
– – ﹤0.01% 2313
2021
Q2 		$160K Hold
4,553
– – ﹤0.01% 2311
2021
Q1 		$160K Hold
4,553
– – ﹤0.01% 2167
2020
Q4 		$171K Buy
4,553
+258
+6% +$9.38K ﹤0.01% 2034
2020
Q3 		$143K Hold
4,295
– – ﹤0.01% 1992
2020
Q2 		$114K Buy
4,295
+867
+25% +$20.5K ﹤0.01% 2180
2020
Q1 		$56.1K Hold
3,428
– – ﹤0.01% 2351
2019
Q4 		$87.1K Buy
3,428
+100
+3% +$2K ﹤0.01% 2405
2019
Q3 		$66.6K Hold
3,328
– – ﹤0.01% 2465
2019
Q2 		$107K Hold
3,328
– – ﹤0.01% 2266
2019
Q1 		$107K Hold
3,328
– – ﹤0.01% 2291
2018
Q4 		$81.6K Hold
3,328
– – ﹤0.01% 2397
2018
Q3 		$110K Hold
3,328
– – ﹤0.01% 2401
2018
Q2 		$118K Buy
+3,328
New +$108K ﹤0.01% 2239

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ALBO Position: Q1 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 1,087 shares — an estimated $23.5K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ALBO in Q2 2018 and held it in 19 quarters. The position peaked at $171K in Q4 2020. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,087 Albireo Pharma Inc shares in Q1 2023, an estimated $23.5K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Albireo Pharma Inc in Q2 2018 and held it in 19 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Albireo Pharma Inc position peaked at $171K in Q4 2020.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2023, filed 15 May 2023.